Replies to post #30387 on Biotech Values

[DewDiligence]

Then that makes Lucentis Avastin’s nephew? :-)

[north40000]

AMD---GNVC trial

Last February I posted the following article link on the DNA YMB re some interesting data evolving from GNVC's gene
therapy approach:

http://tinyurl.com/m6wxl

Early results to be sure. DNA owned[may still own] a block of GNVC. I do not know current status of above. GNVC is pursuing its pancreatic and esophogeal cancer indications at the present
time.

Do you or DEW have any further views re results reported in article, particularly beyond what you observed at the time?

[bladerunner1717]

re: Avastin and Lucentis

Master and Dew,

How have the retinal docs been dealing with the liability issues by using Avastin in an off-label indication like AMD, especially in light of DNA's warnings to docs on this issue?


Bladerunner